Akebia Therapeutics, Inc.
AKBA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001517022
No open-market purchases or sales by Akebia Therapeutics, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $123.2M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Akebia Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 139 | 2 | 127 | −10 |
| Shares | 106.2M | 122.1K | 98.5M | −7.56M (−7.1%) |
| Value | $402.4M | $463.0K | $283.7M | −$118.3M (−29.4%) |
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Akebia Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kennedy Capital Management, Inc. | 367,874 | $1.06M | 0.02% |
| Opaleye Management Inc. | 311,300 | $897.0K | 0.17% |
| Gsa Capital Partners LLP | 254,376 | $733.0K | 0.07% |
| Franklin Resources Inc | 122,000 | $351.0K | 0.00% |
| Maverick Capital LtdSuperinvestorMaverick Capital | 105,816 | $305.0K | 0.00% |
| E Fund Management Co., Ltd. | 37,123 | $107.0K | 0.00% |
| Two Sigma Securities, LLC | 21,361 | $62.0K | 0.01% |
| Janus Henderson Group PLC | 14,745 | $42.0K | 0.00% |
| FMR LLC | 37 | $0 | 0.00% |
| First Horizon Advisors, Inc. | 63 | $0 | 0.00% |
| Gerber Kawasaki Wealth & Investment Management | 50 | $0 | 0.00% |
| Meridian Wealth Partners, LLC | 266 | $0 | 0.00% |
Sold out (22)
Institutions that held Akebia Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Wellington Management Group LLP | 10,736,859 | $40.7M |
| Mirabella Financial Services LLP | 267,603 | $1.01M |
| Millennium Management LLC | 264,954 | $1.00M |
| HRT Financial LP | 62,446 | $236.0K |
| Tudor Investment Corp Et Al | 51,044 | $193.0K |
| Virtu Financial LLC | 46,270 | $175.0K |
| Voloridge Investment Management, LLC | 41,781 | $158.0K |
| Qube Research & Technologies Ltd | 41,564 | $158.0K |
| XTX Topco Ltd | 20,589 | $78.0K |
| Gotham Asset Management, LLC | 19,195 | $73.0K |
| Quantitative Systematic Strategies LLC | 18,732 | $71.0K |
| Point72 Hong Kong Ltd | 18,451 | $70.0K |
| Bridgefront Capital, LLC | 17,189 | $65.0K |
| Acadian Asset Management LLC | 10,636 | $40.0K |
| Pinz Capital Management, LP | 6,300 | $24.0K |
| Quadrant Capital Group LLC | 947 | $4.00K |
| Magnus Financial Group LLC | 1,000 | $4.00K |
| TCI Wealth Advisors, Inc. | 843 | $3.00K |
| US Bancorp | 309 | $1.00K |
| Lindbrook Capital, LLC | 207 | $1.00K |
| Dark Forest Capital Management LP | 383 | $1.00K |
| Toronto Dominion Bank | 22 | $0 |
Not filed for Q3 2021 yet (2)
Institutions that held Akebia Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 122,000 | $463.0K |
| First Horizon Corp | 63 | $0 |